Wire · opportunities
FDA approves Sanofi's Sarclisa Escena, first anticancer treatment administered via on-body injector
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 10 July 2026 · Fusion42 review
FDA approves Sarclisa Escena, a subcutaneous formulation of Sanofi's multiple myeloma drug administered via Enable Injections' on-body injector, matching IV efficacy with shorter treatment time and fewer infusion-related reactions.
This Wire brief sits within Fusion42's coverage of Digital Health.
◆ ◆ The Wire takeaway
If you're building drug-delivery devices, pharma giants now need you to solve the patient experience problem they've ignored for decades. Sanofi just proved that a simpler injector beats IV infusions on efficacy and comfort—that's a commercial template for every high-volume cancer therapy on the market.
◆ Coverage
1 source · 10 Jul 2026
◆ Related on Wire
◆ Topics